Form 8-K Sucampo Pharmaceuticals, For: Aug 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook
August 5, 2014 6:43 AM EDTSucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $24.1 million versus the consensus estimate of $24.06 million.
Sucampo Pharmaceuticals, Inc. sees FY2014 EPS of $0.08-$0.13, versus the consensus of $0.18.
For earnings... More



